XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Revenues:        
Product sales $ 11,213 $ 13,168 $ 21,700 $ 23,845
Cost of revenues 6,288 5,991 11,943 11,365
Gross profit 4,925 7,177 9,757 12,480
Operating expenses        
Selling, general and administrative 6,054 5,811 12,439 11,009
Research and development 2,281 1,893 4,216 3,607
Total operating expenses 8,335 7,704 16,655 14,616
Loss from operations (3,410) (527) (6,898) (2,136)
Other income (expense), net 15 (10) (4) 3
Loss before income taxes (3,395) (537) (6,902) (2,133)
Income tax expense (benefit) 8 (45) 8 (336)
Net loss $ (3,403) $ (492) $ (6,910) $ (1,797)
Net loss per common share - basic and diluted (in dollars per share) $ (0.09) $ (0.01) $ (0.19) $ (0.05)
Weighted average common shares outstanding:        
Basic and diluted (in shares) 36,817,026 36,353,321 36,755,920 36,405,321
Product [Member]        
Revenues:        
Product sales $ 9,940 $ 11,854 $ 19,058 $ 21,424
Service [Member]        
Revenues:        
Product sales $ 1,273 $ 1,314 $ 2,642 $ 2,421